Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study

A. Santoro, H. Bredenfeld, L. Devizzi, H. Tesch, V. Bonfante, S. Viviani, F. Fiedler, H. Soto Parra, C. Benoehr, M. Pacini, G. Bonadonna, V. Diehl

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences